FindTrial
Sign In

Influence of Hormone Therapy on Heart Attack Incidence in Men Undergoing Prostate Brachytherapy

Influence of Androgen Suppression Therapy for Prostate Cancer on the Timing and Onset of Fatal Myocardial Infarctions in Men Undergoing Prostate Brachytherapy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00651222
Enrollment
Unknown
Registered
2008-04-02
Start date
Unknown
Completion date
Unknown
Last updated
2008-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Death, Prostate Cancer

Brief summary

The purpose of this study is to review cause of death in patients undergoing prostate brachytherapy at a single institution. Furthermore, we are analyzing patients undergoing androgen deprivation therapy and whether or not this contributed to cardiovascular deaths, specifically myocardial infarction.

Interventions

OTHERNo intervention was required

Death records were reviewed, therefore, there was no intervention

Sponsors

Prostate Cancer Foundation of Chicago
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
MALE
Healthy volunteers
No

Inclusion criteria

* Deceased anytime after prostate brachytherapy treatment

Exclusion criteria

* Patients whose cause of death was unable to be determined

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026